Characterization and comparison of human glioblastoma models

Glioblastoma (GBM) is one of the deadliest cancers. Treatment options are limited, and median patient survival is only several months. Translation of new therapies is hindered by a lack of GBM models that fully recapitulate disease heterogeneity. Here, we characterize two human GBM models (U87-luc2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Julia A., Rodgers, Louis T., Kryscio, Richard J., Hartz, Anika M.S., Bauer, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347152/
https://www.ncbi.nlm.nih.gov/pubmed/35922758
http://dx.doi.org/10.1186/s12885-022-09910-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347152/
https://www.ncbi.nlm.nih.gov/pubmed/35922758
http://dx.doi.org/10.1186/s12885-022-09910-9

Ejemplares similares